Table 5 Continuous T3 and risk of specific prognostic factors in breast cancer in postmenopausal women

All

2.87 (1.86-4.43)

2.85 (1.86–4.37)

2.88 (1.90-4.37)

Grade I

2.32 (0.85-6.36)

2.35 (0.82-6.75)

2.37 (0.83-6.77)

Grade II

4.12 (2.19-7.77)

3.99 (2.17-7.36)

3.98 (2.19-7.23)

Grade III

1.18 (0.39-3.55)

1.24 (0.42-3.67)

1.30 (0.45-3.81)

Size ≤20 mm

3.28 (1.86-5.76)

3.31 (1.86-5.89)

3.33 (1.89-5.86)

Size >20 mm

1.64 (0.63-4.26)

1.76 (0.71-4.33)

1.83 (0.76-4.42)

Node positive

3.44 (1.54-7.66)

3.35 (1.59-7.07)

3.37 (1.63-6.96)

Node negative

2.08 (1.05-4.10)

2.08 (1.05-4.10)

2.12 (1.08-4.15)

ER positive

2.44 (1.38-4.32)

2.44 (1.39-4.29)

2.48 (1.43-4.31)

ER negative

4.83 (2.18-10.69)

4.72 (2.16-10.29)

4.69 (2.19-10.06)

PGR positive

2.59 (1.44-4.65)

2.59 (1.45-4.63)

2.62 (1.48-4.63)

PGR negative

3.87 (1.79-8.33)

3.79 (1.81-7.96)

3.81 (1.85-7.84)